[8-K] SBC Medical Group Holdings Incorporated Reports Material Event
SBC Medical Group Holdings Incorporated furnished a press release and an investor presentation reporting results for the quarter ended June 30, 2025. The press release is included as Exhibit 99.1 and the investor presentation as Exhibit 99.2, with the presentation available on the company website at https://sbc-holdings.com/en/ir/ir-presentation. The report specifies these items are furnished, not filed under the Exchange Act and therefore are not subject to Section 18 liabilities. The company identifies as an emerging growth company and lists its common stock (SBC) and redeemable warrants (SBCWW) on The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated ha diffuso un comunicato stampa e una presentazione per gli investitori con i risultati del trimestre chiuso al 30 giugno 2025. Il comunicato è incluso come Exhibit 99.1 e la presentazione come Exhibit 99.2, con la presentazione disponibile sul sito della società all'indirizzo https://sbc-holdings.com/en/ir/ir-presentation. Il rapporto specifica che questi documenti sono forniti, non depositati ai sensi dell'Exchange Act e pertanto non sono soggetti alle responsabilità previste dalla Section 18. La società si identifica come emerging growth company e registra le proprie azioni ordinarie (SBC) e i warrant rimborsabili (SBCWW) presso The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated publicó un comunicado de prensa y una presentación para inversores con los resultados del trimestre cerrado el 30 de junio de 2025. El comunicado se incluye como Exhibit 99.1 y la presentación como Exhibit 99.2, estando la presentación disponible en la web de la compañía en https://sbc-holdings.com/en/ir/ir-presentation. El informe especifica que estos documentos son proporcionados, no presentados conforme al Exchange Act y, por tanto, no están sujetos a las responsabilidades de la Sección 18. La compañía se identifica como una emerging growth company y cotiza sus acciones ordinarias (SBC) y warrants redimibles (SBCWW) en The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated는 2025년 6월 30일로 종료된 분기 실적을 알리는 보도자료와 투자자 프레젠테이션을 제공했습니다. 보도자료는 Exhibit 99.1로, 프레젠테이션은 Exhibit 99.2로 포함되어 있으며 프레젠테이션은 회사 웹사이트 https://sbc-holdings.com/en/ir/ir-presentation에서도 확인할 수 있습니다. 보고서는 해당 자료들이 Exchange Act에 따라 제출된 것이 아니라 제공된 것(furnished, not filed)으로, 따라서 Section 18의 책임 대상이 아니라고 명시하고 있습니다. 회사는 스스로를 emerging growth company로 규정하며 보통주(SBC)와 상환형 워런트(SBCWW)를 The Nasdaq Stock Market LLC에 상장하고 있습니다.
SBC Medical Group Holdings Incorporated a diffusé un communiqué de presse et une présentation aux investisseurs faisant état des résultats du trimestre clos le 30 juin 2025. Le communiqué est inclus en tant que Exhibit 99.1 et la présentation en tant que Exhibit 99.2, la présentation étant disponible sur le site de la société à l'adresse https://sbc-holdings.com/en/ir/ir-presentation. Le rapport précise que ces éléments sont communiqués, non déposés en vertu de l'Exchange Act et ne sont donc pas soumis aux responsabilités prévues par la Section 18. La société se qualifie d'emerging growth company et inscrit ses actions ordinaires (SBC) ainsi que ses warrants remboursables (SBCWW) auprès de The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated hat eine Pressemitteilung und eine Investorenpräsentation mit den Ergebnissen für das Quartal zum 30. Juni 2025 veröffentlicht. Die Pressemitteilung ist als Exhibit 99.1 und die Präsentation als Exhibit 99.2 beigefügt; die Präsentation ist zudem auf der Unternehmenswebsite unter https://sbc-holdings.com/en/ir/ir-presentation verfügbar. Der Bericht stellt klar, dass diese Unterlagen gemäß dem Exchange Act zur Verfügung gestellt, nicht eingereicht wurden und daher nicht den Haftungsbestimmungen der Section 18 unterliegen. Das Unternehmen bezeichnet sich als emerging growth company und führt seine Stammaktien (SBC) sowie rückzahlbare Warrants (SBCWW) an der The Nasdaq Stock Market LLC.
- None.
- None.
Insights
TL;DR The 8-K furnishes Q2 materials but contains no financial data in the filing itself, so investor impact is limited.
As provided, the filing supplies a press release and investor presentation for the quarter ended June 30, 2025, attached as Exhibits 99.1 and 99.2. The company explicitly states these materials are furnished rather than filed under the Exchange Act, which limits legal liability under Section 18. From the document alone there are no results or metrics to evaluate, so the filing functions as routine disclosure of investor materials rather than a material event.
Impact assessment: not impactful
TL;DR Routine disclosure of investor communications; governance implications minimal based on this filing alone.
The current report documents that a press release and an investor presentation concerning the quarter ended June 30, 2025 were furnished and tied to Exhibits 99.1 and 99.2. The filing also indicates the registrant is an emerging growth company and confirms securities trading symbols (SBC and SBCWW) on Nasdaq. Because the materials are furnished and not filed, the registrant limits incorporation and Section 18 exposure. No governance actions, officer changes, or material transactions are disclosed in this report.
Impact assessment: not impactful
SBC Medical Group Holdings Incorporated ha diffuso un comunicato stampa e una presentazione per gli investitori con i risultati del trimestre chiuso al 30 giugno 2025. Il comunicato è incluso come Exhibit 99.1 e la presentazione come Exhibit 99.2, con la presentazione disponibile sul sito della società all'indirizzo https://sbc-holdings.com/en/ir/ir-presentation. Il rapporto specifica che questi documenti sono forniti, non depositati ai sensi dell'Exchange Act e pertanto non sono soggetti alle responsabilità previste dalla Section 18. La società si identifica come emerging growth company e registra le proprie azioni ordinarie (SBC) e i warrant rimborsabili (SBCWW) presso The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated publicó un comunicado de prensa y una presentación para inversores con los resultados del trimestre cerrado el 30 de junio de 2025. El comunicado se incluye como Exhibit 99.1 y la presentación como Exhibit 99.2, estando la presentación disponible en la web de la compañía en https://sbc-holdings.com/en/ir/ir-presentation. El informe especifica que estos documentos son proporcionados, no presentados conforme al Exchange Act y, por tanto, no están sujetos a las responsabilidades de la Sección 18. La compañía se identifica como una emerging growth company y cotiza sus acciones ordinarias (SBC) y warrants redimibles (SBCWW) en The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated는 2025년 6월 30일로 종료된 분기 실적을 알리는 보도자료와 투자자 프레젠테이션을 제공했습니다. 보도자료는 Exhibit 99.1로, 프레젠테이션은 Exhibit 99.2로 포함되어 있으며 프레젠테이션은 회사 웹사이트 https://sbc-holdings.com/en/ir/ir-presentation에서도 확인할 수 있습니다. 보고서는 해당 자료들이 Exchange Act에 따라 제출된 것이 아니라 제공된 것(furnished, not filed)으로, 따라서 Section 18의 책임 대상이 아니라고 명시하고 있습니다. 회사는 스스로를 emerging growth company로 규정하며 보통주(SBC)와 상환형 워런트(SBCWW)를 The Nasdaq Stock Market LLC에 상장하고 있습니다.
SBC Medical Group Holdings Incorporated a diffusé un communiqué de presse et une présentation aux investisseurs faisant état des résultats du trimestre clos le 30 juin 2025. Le communiqué est inclus en tant que Exhibit 99.1 et la présentation en tant que Exhibit 99.2, la présentation étant disponible sur le site de la société à l'adresse https://sbc-holdings.com/en/ir/ir-presentation. Le rapport précise que ces éléments sont communiqués, non déposés en vertu de l'Exchange Act et ne sont donc pas soumis aux responsabilités prévues par la Section 18. La société se qualifie d'emerging growth company et inscrit ses actions ordinaires (SBC) ainsi que ses warrants remboursables (SBCWW) auprès de The Nasdaq Stock Market LLC.
SBC Medical Group Holdings Incorporated hat eine Pressemitteilung und eine Investorenpräsentation mit den Ergebnissen für das Quartal zum 30. Juni 2025 veröffentlicht. Die Pressemitteilung ist als Exhibit 99.1 und die Präsentation als Exhibit 99.2 beigefügt; die Präsentation ist zudem auf der Unternehmenswebsite unter https://sbc-holdings.com/en/ir/ir-presentation verfügbar. Der Bericht stellt klar, dass diese Unterlagen gemäß dem Exchange Act zur Verfügung gestellt, nicht eingereicht wurden und daher nicht den Haftungsbestimmungen der Section 18 unterliegen. Das Unternehmen bezeichnet sich als emerging growth company und führt seine Stammaktien (SBC) sowie rückzahlbare Warrants (SBCWW) an der The Nasdaq Stock Market LLC.
FAQ
What did SBC (SBC) disclose in this 8-K?
Are the press release and presentation filed with the SEC?
Where can investors find the investor presentation for SBC?
What securities of SBC are registered for trading?
Does the 8-K indicate any executive changes or major transactions?
